Myelodysplastic Syndromes, Previously Treated: Clinical Trials

2 trials for Myelodysplastic Syndromes, Previously Treated, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1

Follow Myelodysplastic Syndromes, Previously Treated: new trials by email Literature Review of Myelodysplastic Syndromes, Previously Treated trials Research Report on Myelodysplastic Syndromes, Previously Treated

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary
Phase 1RecruitingAndrew E. Place, MD302023-03-292026-03-12
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
CPX-351, Fludarabine, Melphalan - Myelodysplastic Syndromes, Leukemia, Myeloid, Acute
Phase 1CompletedWeill Medical College of Cornell University142012-11-302022-12-21

Narrower conditions

Myelodysplastic Syndromes (2)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Neoplasm Metastasis (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Broader conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)

Interventions

Antilymphocyte Serum (1)  ·  Azacitidine (1)  ·  CPX-351 (1)  ·  Cortisone (1)  ·  Cytarabine (1)  ·  Dexamethasone (1)  ·  Dexrazoxane (1)  ·  Doxorubicin (1)  ·  Hydrocortisone (1)  ·  Leucovorin (1)  ·  Melphalan (1)  ·  Methotrexate (1)  ·  Vincristine (1)  ·  asparaginase erwinia chrysanthemi recombinant (1)  ·  calaspargase pegol (1)

Sponsors

Andrew E. Place, MD (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (2)

Top investigators

Andrew E Place, MD, PhD (1)  ·  Sebastian Mayer, MD (1)